D
S. K. Mandal et al.
Letter
Synlett
(11) (a) Sham, H. L.; Wideburg, N. E.; Spanton, S. G.; Kohlbrenner, W.
E.; Betebenner, D. A.; Kempf, D. J.; Norbeck, D. W.; Plattner, J. J.;
Erickson, J. W. J. Chem. Soc., Chem. Commun. 1991, 110.
(b) Thaisrivongs, S.; Schostarez, H.; Pals, D. T.; Turner, S. R.
J. Med. Chem. 1987, 30, 1837.
(12) (a) Kirsch, P. Modern Fluoroorganic Chemistry. Synthesis, Reac-
tivity, Applications; Wiley-VCH: Weinheim, 2004. (b) Rivkin, A.;
Yoshimura, F.; Gabarda, A. E.; Cho, Y. S.; Chou, T.-C.; Dong, H.;
Danishefsky, S. J. J. Am. Chem. Soc. 2004, 126, 10913.
(20) (a) Li, B.; Masuda, S.; Minato, D.; Zhou, D.; Sugimoto, K.;
Nemoto, H.; Matsuya, Y. Tetrahedron 2014, 70, 3981. (b) Calata,
C.; Pfund, E.; Lequeux, T. Tetrahedron 2011, 67, 1398. (c) Ghosh,
A. K.; Banerjee, S.; Sinha, S.; Kang, S. B.; Zajc, B. J. Org. Chem.
2009, 74, 3689. (d) Zajc, B.; Kake, S. Org. Lett. 2006, 8, 4457.
(21) (a) Mandal, S. K.; Ghosh, A. K. Kumar R.; Zajc, B. Org. Biomol.
Chem. 2012, 10, 3164. (b) Chowdhury, M.; Mandal, S. K.;
Banerjee, S.; Zajc, B. Molecules 2014, 19, 4418. (c) Ayeni, D. O.;
Mandal, S. K.; Zajc, B. Tetrahedron Lett. 2013, 54, 6008.
(22) Yuasa, Y.; Shibuya, S.; Yuasa, Y. Synth. Commun. 2003, 33, 3947.
(23) Lee, K.; Kim, H.; Hong, J. Org. Lett. 2009, 11, 5202.
(24) 3-Hydroxy-3-phenylpropanal (4a); Typical Oxidation Proce-
dure
(13) (a) Smart, B. E. J. Fluorine Chem. 2001, 109, 3. (b) Lemal, D. M.
J. Org. Chem. 2004, 69, 1. (c) O’Hagan, D. Chem. Soc. Rev. 2008,
37, 308.
(14) (a) Ono, T.; Hayakawa, H.; Yasuda, N.; Uekusa, H.; Ohashi, Y. In
Current Fluoroorganic Chemistry: New Synthetic Directions, Tech-
nologies, Materials, and Biological Applications; Soloshonok, V.
A.; Mikami, K.; Yamazaki, T.; Welch, J. T.; Honek, J. F., Eds.; ACS
Symposium Series 949: Washington, 2007, Chap. 10 170.
(b) Bégué, J.-P.; Bonnet-Delpon, D. J. Fluorine Chem. 2006, 127,
992. (c) Alonso, D. A.; Fuensanta, M.; Gómez-Bengoa, E.; Nájera,
C. Adv. Synth. Catal. 2008, 350, 1823. (d) Chevrie, D.; Lequeux,
T.; Pommelet, J.-C. Tetrahedron 2002, 58, 4759. (e) Hara, S.;
Yamamoto, K.; Yoshida, M.; Fukuhara, T.; Yoneda, N. Tetrahe-
dron Lett. 1999, 40, 7815. (f) Chevrie, D.; Lequeux, T.; Demoute,
J. P.; Pazenok, S. Tetrahedron Lett. 2003, 44, 8127.
(g) Champagne, P. A.; Desroches, J.; Hamel, J.-D.; Vandamme,
M.; Paquin, J.-F. Chem. Rev. 2015, 115, 9073. (h) Yanai, H.;
Taguchi, T. Eur. J. Org. Chem. 2011, 5939.
To a solution of 1-phenylbut-3-en-1-ol (5a; 150 mg, 1.01 mmol)
in 3:1 1,4-dioxane/H2O (10 mL) at r.t. were successively added
2.5% OsO4 in t-BuOH (0.18 mL; 0.022 mmol) and 2,6-lutidine
(0.24 mL, 2.02 mmol). NaIO4 (864 mg, 4.04 mmol) was then
added in portions over 30 min, and the mixture was stirred at
r.t. for 2 h. The reaction was quenched by addition of H2O (10
mL), and the mixture was diluted with Et2O (20 mL). The layers
were separated, and the aqueous layer was extracted with Et2O
(2 × 50 mL). The organic layers were combined, washed with
H2O (2 × 25 mL) and brine (25 mL), then dried (Na2SO4), filtered,
and concentrated in vacuo to give the crude product, which was
used directly in the condensation reaction.
(25) Ethyl (2E)-2-Fluoro-5-hydroxy-5-phenylpent-2-enoate (2a)
and Ethyl (2Z)-2-Fluoro-5-hydroxy-5-phenylpent-2-enoate
(IIa); Typical Condensation Procedure
(15) Jeschke, P. ChemBioChem 2004, 5, 570.
(16) Bégué, J.-P.; Bonnet-Delpon, D. Bioorganic and Medicinal Chem-
istry of Fluorine; Wiley: Hoboken, 2008.
Cs2CO3 (780 mg, 2.4 mmol) was added to a stirred solution of
the crude 4a and sulfone 3 (366 mg, 1.2 mmol) in CH2Cl2 (10
mL) at r.t., and the mixture was stirred overnight. The solids
were removed by filtration, and the solvent was removed in
vacuo. The crude product was purified by column chromatogra-
phy [silica gel (100–200 mesh) EtOAc/PE (4:1)] to give a mixture
of 2a and IIa; yield: 147 mg (62%)
(17) (a) Burton, D. J.; Yang, Z.-Y.; Qiu, W. Chem. Rev. 1996, 96, 1641.
(b) Barros, M. E. S. B.; Freitas, J. C. R.; Oliveira, J. M.; da Cruz, C. H.
B.; da Silva, P. B. N.; de Araújo, L. C. C.; Militão, G. C. G.; da Silva,
T. G.; Oliveira, R. A.; Menezes, P. H. Eur. J. Med. Chem. 2014, 76,
291. (c) Oliveira, J. M.; Freitas, J. C. R.; Comasseto, J. V.; Menezes,
P. H. Tetrahedron 2011, 67, 3003. (d) Nokami, J.; Anthony, L.;
Sumida, S.-I. Chem. Eur. J. 2000, 6, 2909.
(26) 3-Fluoro-6-phenyl-5,6-dihydro-2H-pyran-2-one (1a): Typical
Lactonization Procedure
(18) (a) Kocienski, P. J.; Bell, A.; Blakemore, P. R. Synlett 2000, 365.
(b) Zajc, B.; Kumar, R. Synthesis 2010, 1822. (c) Baudin, J. B.;
Hareau, G.; Julia, S. A.; Ruel, O. Tetrahedron Lett. 1991, 32, 1175.
(19) (a) Paira, M.; Banerjee, B.; Jana, S.; Mandal, S. K.; Roy, S. C. Tetra-
hedron Lett. 2007, 48, 3205. (b) Mandal, S. K.; Roy, S. C. Tetrahe-
dron Lett. 2007, 48, 4131. (c) Mandal, S. K.; Roy, S. C. Tetrahedron
2008, 64, 11050. (d) Mandal, S. K.; Paira, M.; Roy, S. C. J. Org.
Chem. 2008, 73, 3823. (e) Saha, S.; Mandal, S. K.; Roy, S. C. Tetra-
hedron Lett. 2011, 52, 3128.
The mixture of 2a and IIa obtained from the condensation reac-
tion was treated with CSA (5 mg, 2 mol%) in CH2Cl2 (10 mL) at
r.t. overnight. The resulting mixture was concentrated and puri-
fied by column chromatography [silica gel (100–200 mesh),
CH2Cl2] to give a white solid; yield: 63 mg (33% overall); mp
82 °C.
IR (KBr) 1743, 1674, 1164, 769 cm–1. 1H NMR (400 MHz, CDCl3):
δ = 2.66–2.74 (m, 1 H), 2.83–2.93 (m, 1 H), 5.54 (dd, J = 4.0,
12.0 Hz, 1 H), 6.36–6.40 (m, 1 H), 7.36–7.48 (m, 5 H). 13C NMR
3
(100 MHz, CDCl3): δ = 30.6 (d, JCF = 4.0 Hz), 80.0, 118.0 (d,
2JCF = 13.0 Hz), 126.1 (2 C), 128.9 (2 C), 129.1, 137.4, 147.6 (d,
2
1JCF = 258.0 Hz), 158.9 (d, JCF = 31.0 Hz). HRMS: m/z [M + H]
calcd for C11H10FO2: 193.0665; found: 193.0668.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2017, 28, A–D